<VariationArchive VariationID="1387616" VariationName="NM_001482.3(GATM):c.724_725del (p.Gly242fs)" VariationType="Deletion" Accession="VCV001387616" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2022-03-28" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1474340" VariationID="1387616">
      <GeneList>
        <Gene Symbol="GATM" FullName="glycine amidinotransferase" GeneID="2628" HGNC_ID="HGNC:4175" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="45361124" stop="45402227" display_start="45361124" display_stop="45402227" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="45653321" stop="45670979" display_start="45653321" display_stop="45670979" Strand="-" />
          </Location>
          <OMIM>602360</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001482.3(GATM):c.724_725del (p.Gly242fs)</Name>
      <CanonicalSPDI>NC_000015.10:45366458:CCC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="45366459" stop="45366460" display_start="45366459" display_stop="45366460" variantLength="2" positionVCF="45366458" referenceAlleleVCF="TCC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="45658657" stop="45658658" display_start="45658657" display_stop="45658658" variantLength="2" positionVCF="45658656" referenceAlleleVCF="TCC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>G242fs</ProteinChange>
      <ProteinChange>G113fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.45366460_45366461del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.45366460_45366461del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.45658658_45658659del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.45658658_45658659del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011674.2" sequenceAccession="NG_011674" sequenceVersion="2" change="g.40858_40859del">
            <Expression>NG_011674.2:g.40858_40859del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001321015.2" sequenceAccession="NM_001321015" sequenceVersion="2" change="c.337_338del">
            <Expression>NM_001321015.2:c.337_338del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001307944.1" sequenceAccession="NP_001307944" sequenceVersion="1" change="p.Gly113fs">
            <Expression>NP_001307944.1:p.Gly113fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001482.3" sequenceAccession="NM_001482" sequenceVersion="3" change="c.724_725del" MANESelect="true">
            <Expression>NM_001482.3:c.724_725del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001473.1" sequenceAccession="NP_001473" sequenceVersion="1" change="p.Gly242fs">
            <Expression>NP_001473.1:p.Gly242fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2140641896" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001482.3(GATM):c.724_725del (p.Gly242fs) AND Arginine:glycine amidinotransferase deficiency" Accession="RCV001884143" Version="3">
        <ClassifiedConditionList TraitSetID="1986">
          <ClassifiedCondition DB="MedGen" ID="C2675179">Arginine:glycine amidinotransferase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-09-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-09-15" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11555793</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1986" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4606" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">L-Arginine:Glycine Amidinotransferase Deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AGAT deficiency</ElementValue>
                <XRef ID="AGAT+Deficiency/261" DB="Genetic Alliance" />
                <XRef ID="MONDO:0012996" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Arginine:glycine amidinotransferase deficiency</ElementValue>
                <XRef ID="702440000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebral creatine deficiency syndrome 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Creatine deficiency syndrome due to AGAT deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GATM deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CCDS3</ElementValue>
                <XRef Type="MIM" ID="612718" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10323" />
                <XRef ID="10323" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The creatine deficiency disorders (CDDs), inborn errors of creatine metabolism and transport, comprise three disorders: the creatine biosynthesis disorders guanidinoacetate methyltransferase (GAMT) deficiency and L-arginine:glycine amidinotransferase (AGAT) deficiency; and creatine transporter (CRTR) deficiency. Developmental delay and cognitive dysfunction or intellectual disability and speech-language disorder are common to all three CDDs. Onset of clinical manifestations of GAMT deficiency (reported in ~130 individuals) is between ages three months and two years; in addition to developmental delays, the majority of individuals have epilepsy and develop a behavior disorder (e.g., hyperactivity, autism, or self-injurious behavior), and about 30% have movement disorder. AGAT deficiency has been reported in 16 individuals; none have had epilepsy or movement disorders. Clinical findings of CRTR deficiency in affected males (reported in ~130 individuals) in addition to developmental delays include epilepsy (variable seizure types and may be intractable) and behavior disorders (e.g., attention deficit and/or hyperactivity, autistic features, impulsivity, social anxiety), hypotonia, and (less commonly) a movement disorder. Poor weight gain with constipation and prolonged QTc on EKG have been reported. While mild-to-moderate intellectual disability is commonly observed up to age four years, the majority of adult males with CRTR deficiency have been reported to have severe intellectual disability. Females heterozygous for CRTR deficiency are typically either asymptomatic or have mild intellectual disability, although a more severe phenotype resembling the male phenotype has been reported.</Attribute>
                <XRef ID="NBK3794" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301745</ID>
                <ID Source="BookShelf">NBK3794</ID>
              </Citation>
              <XRef ID="35704" DB="Orphanet" />
              <XRef ID="C2675179" DB="MedGen" />
              <XRef ID="MONDO:0012996" DB="MONDO" />
              <XRef Type="MIM" ID="612718" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4173275" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="14735343|MedGen:C2675179" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002148338" DateUpdated="2024-02-20" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-09-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11555793</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. This variant has not been reported in the literature in individuals affected with GATM-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gly242Lysfs*6) in the GATM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GATM are known to be pathogenic (PMID: 11555793).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GATM" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.9:g.45658657_45658658del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2675179" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4173275" TraitType="Disease" MappingType="XRef" MappingValue="C2675179" MappingRef="MedGen">
        <MedGen CUI="C2675179" Name="Arginine:glycine amidinotransferase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

